Enhancement of anticancer effect of interferon-γ gene transfer against interferon-γ-resistant tumor by depletion of tumor-associated macrophages

Molecular Pharmaceutics

Volumn 11, Issue 5, 2014, Pages 1542-1549

  Kiyota, Tsuyoshi ^a   Takahashi, Yuki ^a   Watcharanurak, Kanitta ^a   Nishikawa, Makiya ^a   Ohara, Saori ^a   Ando, Mitsuru ^a   Watanabe, Yoshihiko ^a   Takakura, Yoshinobu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

clodronate liposome; interferon; plasmid DNA; tumor associated macrophage

Indexed keywords

ANTINEOPLASTIC AGENT; CLODRONIC ACID; GAMMA INTERFERON; MACROGOL; MACROGOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER GENE THERAPY; CONTROLLED STUDY; CYTOTOXICITY; GENE TRANSFER; MELANOMA B16; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SOLID TUMOR; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR RESISTANCE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMISTRY; CYTOLOGY; GENE THERAPY; GENETICS; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MELANOMA, EXPERIMENTAL; METABOLISM; PHYSIOLOGY; PLASMID; TUMOR CELL CULTURE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; GENETIC THERAPY; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; MACROPHAGES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLASMIDS; POLYETHYLENE GLYCOLS; TUMOR CELLS, CULTURED;

EID: 84899882221     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp4007216     Document Type: Article

References (31)

1. Mantovani, A.; Germano, G.; Marchesi, F.; Locatelli, M.; Biswas, S. K. Cancer-promoting tumor-associated macrophages: New vistas and open questions Eur. J. Immunol. 2011, 41, 2522-2525
2. Mantovani, A.; Schioppa, T.; Porta, C.; Allavena, P.; Sica, A. Role of tumor-associated macrophages in tumor progression and invasion Cancer Metastasis Rev. 2006, 25, 315-322
3. Sica, A.; Bronte, V. Altered macrophage differentiation and immune dysfunction in tumor development J. Clin. Invest. 2007, 117, 1155-1166
4. Weigert, A.; Sekar, D.; Brüne, B. Tumor-associated macrophages as targets for tumor immunotherapy Immunotherapy 2009, 1, 83-95
5. Sica, A.; Schioppa, T.; Mantovani, A.; Allavena, P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy Eur. J. Cancer 2006, 42, 717-727
6. Lin, E. Y.; Nguyen, A. V.; Russell, R. G.; Pollard, J. W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy J. Exp. Med. 2001, 193, 727-739
7. Miller, C. H. T.; Maher, S. G.; Young, H. A. Clinical use of interferon-gamma Ann. N.Y. Acad. Sci. 2009, 1182, 69-79
8. Young, H. A.; Bream, J. H. IFN-gamma: Recent advances in understanding regulation of expression, biological functions, and clinical applications Curr. Top. Microbiol. Immunol. 2007, 316, 97-117
9. Takahashi, Y.; Kaneda, H.; Takasuka, N.; Hattori, K.; Nishikawa, M.; Takakura, Y. Enhancement of antiproliferative activity of interferons by RNA interference-mediated silencing of SOCS gene expression in tumor cells Cancer Sci. 2008, 99, 1650-1655
10. Kawano, H.; Nishikawa, M.; Mitsui, M.; Takahashi, Y.; Kako, K.; Yamaoka, K.; Watanabe, Y.; Takakura, Y. Improved anti-cancer effect of interferon gene transfer by sustained expression using CpG-reduced plasmid DNA Int. J. Cancer 2007, 121, 401-406
11. Mitsui, M.; Nishikawa, M.; Zang, L.; Ando, M.; Hattori, K.; Takahashi, Y.; Watanabe, Y.; Takakura, Y. Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression J. Gene Med. 2009, 11, 435-443
12. Van Rooijen, N.; Sanders, A. Liposome mediated depletion of macropbages: Mechanism of action, preparation of liposomes and applications J. Immunol. Methods 1994, 174, 83-93
13. Takiguchi, N.; Takahashi, Y.; Nishikawa, M.; Matsui, Y.; Fukuhara, Y.; Oushiki, D.; Kiyose, K.; Hanaoka, K.; Nagano, T.; Takakura, Y. Positive correlation between the generation of reactive oxygen species and activation/reactivation of transgene expression after hydrodynamic injections into mice Pharm. Res. 2011, 28, 702-711
14. Ishida, T.; Iden, D. L.; Allen, T. M. A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs FEBS Lett. 1999, 460, 129-133
15. Yoshida, H.; Nishikawa, M.; Yasuda, S.; Mizuno, Y.; Takakura, Y. Cellular activation by plasmid dna in various macrophages in primary culture J. Pharm. Sci. 2008, 97, 4575-4585
16. Ando, M.; Takahashi, Y.; Nishikawa, M.; Watanabe, Y.; Takakura, Y. Constant and steady transgene expression of interferon-gamma by optimization of plasmid construct for safe and effective interferon-gamma gene therapy J. Gene Med. 2012, 14, 288-295
17. Kobayashi, N.; Nishikawa, M.; Takakura, Y. The hydrodynamics-based procedure for controlling the pharmacokinetics of gene medicines at whole body, organ and cellular levels Adv. Drug Delivery Rev. 2005, 57, 713-731
18. Liu, F.; Song, Y. K.; Liu, D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA Gene Ther. 1999, 6, 1258-1266
19. Zeisberger, S. M.; Odermatt, B.; Marty, C.; Zehnder-Fjällman, A. H. M.; Ballmer-Hofer, K.; Schwendener, R. A. Clodronate-liposome-mediated depletion of tumour-associated macrophages: A new and highly effective antiangiogenic therapy approach Br. J. Cancer 2006, 95, 272-281
20. Bingle, L.; Brown, N. J.; Lewis, C. E. The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies J. Pathol. 2002, 196, 254-265
21. Duluc, D.; Corvaisier, M.; Blanchard, S.; Catala, L.; Descamps, P.; Gamelin, E.; Ponsoda, S.; Delneste, Y.; Hebbar, M.; Jeannin, P. Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages Int. J. Cancer 2009, 125, 367-373
22. Duff, M. D.; Mestre, J.; Maddali, S.; Yan, Z. P.; Stapleton, P.; Daly, J. M. Analysis of Gene Expression in the Tumor-Associated Macrophage J. Surg. Res. 2007, 142, 119-128
23. Meng, Y.; Beckett, M. A.; Liang, H.; Mauceri, H. J.; Van Rooijen, N.; Cohen, K. S.; Weichselbaum, R. R. Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy Cancer Res. 2010, 70, 1534-1543
24. Santoni, M.; Massari, F.; Amantini, C.; Nabissi, M.; Maines, F.; Burattini, L.; Berardi, R.; Santoni, G.; Montironi, R.; Tortora, G.; Cascinu, S. Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma Cancer Immunol. Immunother. 2013, 62, 1757-1768
25. De Weerd, N. A.; Nguyen, T. The interferons and their receptors-distribution and regulation Immunol. Cell Biol. 2012, 90, 483-491
26. Leenen, P. J. M.; Radosević, K.; Voerman, J. S. A.; Salomon, B.; Van Rooijen, N.; Klatzmann, D.; Van Ewijk, W. Heterogeneity of mouse spleen dendritic cells: In vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover J. Immunol. 1998, 160, 2166-2173
27. Schmidt-Weber, C. B.; Rittig, M.; Buchner, E.; Hauser, I.; Schmidt, I.; Palombo-Kinne, E.; Emmrich, F.; Kinne, R. W. Apoptotic cell death in activated monocytes following incorporation of clodronate-liposomes J. Leukocyte Biol. 1996, 60, 230-244
28. Hiraoka, K.; Zenmyo, M.; Watari, K.; Iguchi, H.; Fotovati, A.; Kimura, Y. N.; Hosoi, F.; Shoda, T.; Nagata, K.; Osada, H.; Ono, M.; Kuwano, M. Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages Cancer Sci. 2008, 99, 1595-1602
29. Barrera, P.; Blom, A.; Van Lent, P. L. E. M.; Van Bloois, L.; Beijnen, J. H.; Van Rooijen, N.; De Waal Malefijt, M. C.; Van De Putte, L. B. A.; Storm, G.; Van Den Berg, W. B. Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis Arthritis Rheum. 2000, 43, 1951-1959
30. MacDonald, K. P. A.; Palmer, J. S.; Cronau, S.; Seppanen, E.; Olver, S.; Raffelt, N. C.; Kuns, R.; Pettit, A. R.; Clouston, A.; Wainwright, B.; Branstetter, D.; Smith, J.; Paxton, R. J.; Cerretti, D. P.; Bonham, L.; Hill, G. R.; Hume, D. A. An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation Blood 2010, 116, 3955-3963
31. Priceman, S. J.; Sung, J. L.; Shaposhnik, Z.; Burton, J. B.; Torres-Collado, A. X.; Moughon, D. L.; Johnson, M.; Lusis, A. J.; Cohen, D. A.; Iruela-Arispe, M. L.; Wu, L. Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: Combating tumor evasion of antiangiogenic therapy Blood 2010, 115, 1461-1471